June 13, 2019
Terns Pharmaceuticals Initiates a Phase 1 Clinical Trial of TERN-101
Phase 1 study will evaluate the safety and tolerability of TERN-101, an FXR agonist in development for the treatment of…
Pharmaceuticals, Biotechnology and Life Sciences
Phase 1 study will evaluate the safety and tolerability of TERN-101, an FXR agonist in development for the treatment of…
DUBLIN–(BUSINESS WIRE)–The “Global Chronic Myeloid Leukemia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Chronic…
DUBLIN–(BUSINESS WIRE)–The “Global Breast Cancer Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Breast Cancer…
DUBLIN–(BUSINESS WIRE)–The “Advanced Pharmacovigilance” conference has been added to ResearchAndMarkets.com’s offering. This course will be of maximum benefit to those…
Pixantrone has been available to patients since 2012 following a conditional approval in Europe PARIS–(BUSINESS WIRE)–Servier today announced that the…
Rituxan met the primary and secondary endpoints in the Phase III PEMPHIX study Rituxan was the first and only biologic…
Dietary supplementation with BioCell Collagen® significantly reduced facial lines and wrinkles, crow’s feet lines/wrinkles, increased skin elasticity and cutaneous collagen…
Company to Eliminate Internal Research Function and Explore Pipeline Out-licensing Opportunities to Focus the Company’s Resources on XERAVA™ Commercial Success…
SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–Applied BioCode announced today that it has received U.S. Food and Drug Administration 510(k) clearance for…
COLOGNE, Germany–(BUSINESS WIRE)–Cannamedical® Pharma GmbH (Cannamedical), the leading German independent cannabis importer, signed three new supply agreements with Canadian producers…